Consistently, 58% of ESCC samples (29/50) displayed BRE upregulation, whereas only 22% (11/50) of peri-tumor normal esophageal samples displayed BRE upregulation (Figure 1D). This evidence concerns the gene BABAM2 and esophageal squamous cell carcinoma.